Watchmaker Genomics Introduces PCR-Free Whole Genome Sequencing Workflow
The workflow eliminates separate qPCR quantification and manual normalization steps, preparing sequencing-ready libraries in approximately 2.5 hours.
The workflow eliminates separate qPCR quantification and manual normalization steps, preparing sequencing-ready libraries in approximately 2.5 hours.
New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
The assay detected 51% more pathogenic variants and 109% more copy number variants compared to six commercial liquid biopsy assays in prospective validation study.
The FDA has approved Thermo Fisher’s Oncomine Dx Express Test on the Genexus Dx Integrated Sequencer as a companion diagnostic for ZEGFROVY.
Read MoreSeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.
Read MoreA new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
Read MoreNGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Read MoremNGS significantly improves pathogen detection in pulmonary infections, enabling more precision compared to conventional methods.
Read MoreNeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
Read MoreBruker announced major advancements at ESCMID Global, including expanded PCR assay options for its BeGenius system.
Read MoreThermo Fisher Scientific has launched the One Lambda HybriType HLA Plus Typing Flex kit, an NGS hybrid capture assay.
Read MoreChildren’s Hospital Colorado’s new in-house whole-genome sequencing lab is revolutionizing patient care by making genetic testing faster.
Read MoreUltima Genomics has launched UG 100 Solaris, an upgraded sequencing solution that enhances throughput and reduces costs.
Read MoreResearchers have developed a revolutionary method using DNA sequencing to rapidly and precisely measure metabolites critical for health.
Read MoreBaylor Genetics has partnered with Epic’s Aura diagnostics suite, enabling ordering genetic tests and access results directly within the EHR.
Read MoreDatar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read MoreResearchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read MoreOGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read More